Mark Slevin
School of Biology
Chemistry and Health Science
Manchester Metropolitan University
Manchester
UK
Name/email consistency: high
- Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Slevin, M., Matou-Nasri, S., Turu, M., Luque, A., Rovira, N., Badimon, L., Boluda, S., Potempa, L., Sanfeliu, C., de Vera, N., Krupinski, J. Brain Pathol. (2010)
- Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Slevin, M., Badimon, L., Grau-Olivares, M., Ramis, M., Sendra, J., Morrison, M., Krupinski, J. Mol. Biosyst (2010)
- B-cell translocation gene 2 is over-expressed in peri-infarct neurons after ischaemic stroke. Slevin, M., Sanfeliu, C., Turu, M.M., Grau-Olivares, M., Ferrer, I., Boluda, S., Marti-Fabregas, J., Kumar, S., Kumar, P., Krupinski, J. Pathobiology (2009)
- Identification of pro-angiogenic markers in blood vessels from stroked-affected brain tissue using laser-capture microdissection. Slevin, M., Krupinski, J., Rovira, N., Turu, M., Luque, A., Baldellou, M., Sanfeliu, C., de Vera, N., Badimon, L. BMC. Genomics (2009)
- A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease?. Slevin, M., Krupinski, J. Histol. Histopathol. (2009)
- Dynamin and perforin are associated with neovascularisation in advanced carotid plaques. Slevin, M., Ethirajan, P., Molki, M., Gaffney, J., Kumar, S., Kumar, P., Krupinski, J. Front. Biosci. (2008)
- Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. Slevin, M., Krupinski, J., Mitsios, N., Perikleous, C., Cuadrado, E., Montaner, J., Sanfeliu, C., Luque, A., Kumar, S., Kumar, P., Gaffney, J. Eur. J. Neurol. (2008)
- New VEGF antagonists as possible therapeutic agents in vascular disease. Slevin, M., Kumar, P., Wang, Q., Kumar, S., Gaffney, J., Grau-Olivares, M., Krupinski, J. Expert. Opin. Investig. Drugs (2008)
- Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R.C., Kumar, S. Matrix Biol. (2007)
- Identification of differential protein expression associated with development of unstable human carotid plaques. Slevin, M., Elasbali, A.B., Miguel Turu, M., Krupinski, J., Badimon, L., Gaffney, J. Am. J. Pathol. (2006)
- Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Slevin, M., Kumar, P., Gaffney, J., Kumar, S., Krupinski, J. Clin. Sci. (2006)
- Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. Slevin, M., Kumar, S., Gaffney, J. J. Biol. Chem. (2002)
- Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Slevin, M., Krupinski, J., Slowik, A., Kumar, P., Szczudlik, A., Gaffney, J. Stroke (2000)
- Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells. Slevin, M., Kumar, S., He, X., Gaffney, J. Int. J. Cancer (1999)
